Damineh has experience with pre-suit investigations, patent litigation, ITC proceedings, licensing, and due diligence analysis in an array of technologies, including biologics, RNA interference, biotechnology, pharmaceuticals, and medical devices. She has a PhD in Neuropharmacology from Oxford University and a B.S. in Molecular Genetics from King’s College, University of London, with Honors. She held multiple post-doctoral research positions at world-renowned universities and has authored a number of publications and book chapter.
